Talha Badar, Hematology/Oncology Specialist at Mayo Clinic, shared a post on X:
“Happy to share my commentary in Blood Global Hematology․
Key takeaways
- DDX41 variants show population-specific patterns, expanding the mutation spectrum.
- Donor-derived germline mutations impact transplant outcomes, supporting donor screening.
- Gaps remain in germline confirmation and variant classification.
- Standardized testing frameworks are needed to improve risk stratification and care.”
Title: DDX41 variants in focus: germ line to donor-derived MN
Authors: Talha Badar
Read The Full Article.
Other articles featuring Talha Badar on OncoDaily.